Braeutigam M - Search Results

1

A comprehensive comparison of dye-sensitized NiO photocathodes for solar energy conversion.

Wood CJ, Summers GH, Clark CA, Kaeffer N, Braeutigam M, Carbone LR, D'Amario L, Fan K, Farré Y, Narbey S, Oswald F, Stevens LA, Parmenter CD, Fay MW, La Torre A, Snape CE, Dietzek B, Dini D, Hammarström L, Pellegrin Y, Odobel F, Sun L, Artero V, Gibson EA. Wood CJ, et al. Among authors: braeutigam m. Phys Chem Chem Phys. 2016 Apr 28;18(16):10727-38. doi: 10.1039/c5cp05326a. Phys Chem Chem Phys. 2016. PMID: 26734947

2

Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: results of a randomized, hydrocortisone-controlled, double-blind phase II trial.

Siepmann D, Lotts T, Blome C, Braeutigam M, Phan NQ, Butterfass-Bahloul T, Augustin M, Luger TA, Ständer S. Siepmann D, et al. Among authors: braeutigam m. Dermatology. 2013;227(4):353-60. doi: 10.1159/000355671. Epub 2013 Nov 23. Dermatology. 2013. PMID: 24281309 Clinical Trial.

3

Efficacy of pimecrolimus 1% cream in the long term management of atopic hand dermatitis. A double-blind RCT.

Bauer A, Lange N, Matterne U, Meurer M, Braeutigam M, Diepgen TL. Bauer A, et al. Among authors: braeutigam m. J Dtsch Dermatol Ges. 2012 Jun;10(6):426-33. doi: 10.1111/j.1610-0387.2011.07832.x. Epub 2011 Nov 23. J Dtsch Dermatol Ges. 2012. PMID: 22112014 Clinical Trial.

4

Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study.

Jacobi A, Braeutigam M, Mahler V, Schultz E, Hertl M. Jacobi A, et al. Among authors: braeutigam m. Dermatology. 2008;216(2):133-6. doi: 10.1159/000111510. Epub 2008 Jan 23. Dermatology. 2008. PMID: 18216475 Clinical Trial.

5

Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial.

Weissenbacher S, Merkl J, Hildebrandt B, Wollenberg A, Braeutigam M, Ring J, Hofmann H. Weissenbacher S, et al. Among authors: braeutigam m. Br J Dermatol. 2007 Apr;156(4):728-32. doi: 10.1111/j.1365-2133.2006.07669.x. Br J Dermatol. 2007. PMID: 17493072 Clinical Trial.

6

Modulation of atopy patch test and skin prick test by pretreatment with 1% pimecrolimus cream.

Weissenbacher S, Traidl-Hoffmann C, Eyerich K, Katzer K, Braeutigam M, Loeffler H, Hofmann H, Behrendt H, Ring J, Darsow U. Weissenbacher S, et al. Among authors: braeutigam m. Int Arch Allergy Immunol. 2006;140(3):239-44. doi: 10.1159/000093249. Epub 2006 May 10. Int Arch Allergy Immunol. 2006. PMID: 16691030 Clinical Trial.

7

Influence of pimecrolimus cream 1% on different morphological signs of eczema in infants with atopic dermatitis.

Breuer K, Braeutigam M, Kapp A, Werfel T. Breuer K, et al. Among authors: braeutigam m. Dermatology. 2004;209(4):314-20. doi: 10.1159/000080855. Dermatology. 2004. PMID: 15539895 Clinical Trial.

8

Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis.

Meurer M, Fartasch M, Albrecht G, Vogt T, Worm M, Ruzicka T, Altmeyer PJ, Schneider D, Weidinger G, Braeutigam M; CASM-DE-01 Study Group. Meurer M, et al. Among authors: braeutigam m. Dermatology. 2004;208(4):365-72. doi: 10.1159/000078462. Dermatology. 2004. PMID: 15178928 Clinical Trial.

9

Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients.

Faerber L, Braeutigam M, Weidinger G, Mrowietz U, Christophers E, Schulze HJ, Mahrle G, Meffert H, Drechsler S. Faerber L, et al. Among authors: braeutigam m. Am J Clin Dermatol. 2001;2(1):41-7. doi: 10.2165/00128071-200102010-00007. Am J Clin Dermatol. 2001. PMID: 11702620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page